Prognosis Biotech Rapid Test Ag 2019-nCoV Ρινικό Τεστ Ελληνικής Κατασκευής 20 Τεμάχια Μεγαλύτερη προβολή

Prognosis Biotech Rapid Test Ag 2019-nCoV Ρινικό Τεστ Ελληνικής Κατασκευής 20 Τεμάχια

Νέο προϊόν

Prognosis Biotech

Prognosis Biotech Rapid Test Ag 2019-nCoV Ρινικό Τεστ Ελληνικής Κατασκευής 20 Τεμάχια

Περισσότερες λεπτομέρειες

Ρωτήστε για διαθεσιμότητα

22,000 € με Φ.Π.Α

20,755 € χωρίς ΦΠΑ

Specification

LATERAL FLOW KIT CHARACTERISTICS:

■ Lateral flow in cassette format available in 1, 2, 4, 5, 20 or 40 tests

■ Clinical Evaluation Study with 370 specimens (prior confirmed with RT-PCR assay) showed: 96.33% sensitivity & 99.62% specificity

■ Clinical performance with 528 nasal specimens (prior confirmed with RT-PCR assay) showed: 98.59% sensitivity & 99.74% specificity

■ The test provides the option for nasal swab sampling for less patient discomfort

■ Visual interpretation of the results in 15 mins

■ Simple method, no need for special equipment

■ Rapid Test Ag 2019-nCov is confirmed to detect also the new dominant variants of SARS-CoV-2, known as the UK (B.1.1.7), South African (B.1.351) and Brazilian (P.1) variants

■ Shelf Life: 12 months | Storage 4-30 oC

■ The test has received the CE-IVD

■ Test should only be conducted by medical personnel

Product successfully added to the product comparison!